+44 (0)20 7451 4553
Alan joined Torreya Partners in 2011 and works on strategic transactions and financings from our London office. He has recently played a key role in a number of transactions including the Selexis Royalty sale to Ligand and the Inviragen sale to Takeda and also oversees Torreya’s junior staff in London.
Previously, Alan was an Investment Manager at LGV, a UK-based middle-market private equity fund, working primarily on healthcare opportunities. Prior to this, he worked as an advisor to the healthcare team at Booz & Co and at Macquarie Group from 2006 to 2009 where he worked on deals in healthcare, infrastructure and structured finance. Before joining Macquarie, he was a practicing doctor in teaching hospitals in London covering specialties including neurology, infectious diseases, endocrinology, accident and emergency and elderly care and in addition to his MBChB (Hons, University of Liverpool), Alan has an MSc in Finance from INSEAD.